Enjoy complimentary customisation on priority with our Enterprise License!
The carrier screening market size is forecast to increase by USD 2.95 billion at a CAGR of 20.62% between 2023 and 2028. The market is experiencing significant growth due to the increasing prevalence of genetic diseases and disorders. Next-generation sequencing (NGS) technology is a key trend in carrier screening, offering faster and more accurate results. Regulations on carrier screening and research vary globally, adding complexity to the market. For instance, the Egyptian Journal of Medical Human Genetics published a study on carrier screening for Spinal Muscular Atrophy using NGS technology. Mitera, a clinical lab, also utilizes NGS for comprehensive carrier screening. NGS enables the simultaneous identification of multiple genetic variants such as STD, making it a more comprehensive and efficient solution for carrier screening. Ensuring regulatory compliance and maintaining accuracy in DNA sequencing results are critical challenges for market participants.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.